<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Dykema AG</submitter><funding>NIBIB NIH HHS</funding><funding>NHGRI NIH HHS</funding><funding>NCI NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>eadg1487</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10629528</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8(87)</volume><pubmed_abstract>Regulatory T cells (T&lt;sub>reg&lt;/sub>) are conventionally viewed as suppressors of endogenous and therapy-induced antitumor immunity; however, their role in modulating responses to immune checkpoint blockade (ICB) is unclear. In this study, we integrated single-cell RNA-seq/T cell receptor sequencing (TCRseq) of >73,000 tumor-infiltrating T&lt;sub>reg&lt;/sub> (TIL-T&lt;sub>reg&lt;/sub>) from anti-PD-1-treated and treatment-naive non-small cell lung cancers (NSCLC) with single-cell analysis of tumor-associated antigen (TAA)-specific T&lt;sub>reg&lt;/sub> derived from a murine tumor model. We identified 10 subsets of human TIL-T&lt;sub>reg&lt;/sub>, most of which have high concordance with murine TIL-T&lt;sub>reg&lt;/sub> subsets. Only one subset selectively expresses high levels of &lt;i>TNFRSF4&lt;/i> (OX40) and &lt;i>TNFRSF18&lt;/i> (GITR), whose engangement by cognate ligand mediated proliferative programs and NF-κB activation, as well as multiple genes involved in T&lt;sub>reg&lt;/sub> suppression, including &lt;i>LAG3&lt;/i>. Functionally, the OX40&lt;sup>hi&lt;/sup>GITR&lt;sup>hi&lt;/sup> subset is the most highly suppressive ex vivo, and its higher representation among total TIL-T&lt;sub>reg&lt;/sub> correlated with resistance to PD-1 blockade. Unexpectedly, in the murine tumor model, we found that virtually all TIL-T&lt;sub>reg&lt;/sub>-expressing T cell receptors that are specific for TAA fully develop a distinct T&lt;sub>H&lt;/sub>1-like signature over a 2-week period after entry into the tumor, down-regulating &lt;i>FoxP3&lt;/i> and up-regulating expression of &lt;i>TBX21 (&lt;/i>Tbet)&lt;i>, IFNG&lt;/i>, and certain proinflammatory granzymes. Transfer learning of a gene score from the murine TAA-specific T&lt;sub>H&lt;/sub>1-like T&lt;sub>reg&lt;/sub> subset to the human single-cell dataset revealed a highly analogous subcluster that was enriched in anti-PD-1-responding tumors. These findings demonstrate that TIL-T&lt;sub>reg&lt;/sub> partition into multiple distinct transcriptionally defined subsets with potentially opposing effects on ICB-induced antitumor immunity and suggest that TAA-specific TIL-T&lt;sub>reg&lt;/sub> may positively contribute to antitumor responses.</pubmed_abstract><journal>Science immunology</journal><pubmed_title>Lung tumor-infiltrating T&amp;lt;sub&amp;gt;reg&amp;lt;/sub&amp;gt; have divergent transcriptional profiles and function linked to checkpoint blockade response.</pubmed_title><pmcid>PMC10629528</pmcid><funding_grant_id>P30 CA006973</funding_grant_id><funding_grant_id>R37 CA251447</funding_grant_id><funding_grant_id>R01 EB029455</funding_grant_id><funding_grant_id>R01 HG010889</funding_grant_id><funding_grant_id>R01 CA121113</funding_grant_id><funding_grant_id>R01 HG009518</funding_grant_id><funding_grant_id>T32 CA009110</funding_grant_id><funding_grant_id>K99 HG011468</funding_grant_id><funding_grant_id>T32 GM136577</funding_grant_id><funding_grant_id>R01 CA142779</funding_grant_id><pubmed_authors>Nishimoto M</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Bom S</pubmed_authors><pubmed_authors>Taube J</pubmed_authors><pubmed_authors>Mitchell-Flack M</pubmed_authors><pubmed_authors>Smith KN</pubmed_authors><pubmed_authors>Zhan W</pubmed_authors><pubmed_authors>Aye THK</pubmed_authors><pubmed_authors>Cherry CM</pubmed_authors><pubmed_authors>Hou W</pubmed_authors><pubmed_authors>Yegnasubramanian S</pubmed_authors><pubmed_authors>Anagnostou V</pubmed_authors><pubmed_authors>Ionta N</pubmed_authors><pubmed_authors>VanDyke D</pubmed_authors><pubmed_authors>Connor S</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Zhang B</pubmed_authors><pubmed_authors>Dykema AG</pubmed_authors><pubmed_authors>Brahmer JR</pubmed_authors><pubmed_authors>Cheung LS</pubmed_authors><pubmed_authors>Munoz AJ</pubmed_authors><pubmed_authors>Ji H</pubmed_authors><pubmed_authors>Spicer J</pubmed_authors><pubmed_authors>Zeng Z</pubmed_authors><pubmed_authors>Caushi JX</pubmed_authors><pubmed_authors>Tam A</pubmed_authors><pubmed_authors>Singh D</pubmed_authors><pubmed_authors>Forde PM</pubmed_authors><pubmed_authors>Tomasovic LM</pubmed_authors><pubmed_authors>Zhang T</pubmed_authors><pubmed_authors>Li T</pubmed_authors><pubmed_authors>Rashid R</pubmed_authors><pubmed_authors>Rayes R</pubmed_authors><pubmed_authors>Ji Z</pubmed_authors><pubmed_authors>Tirado LE</pubmed_authors><pubmed_authors>Spangler JB</pubmed_authors><pubmed_authors>Sawosik CA</pubmed_authors><pubmed_authors>Yang S</pubmed_authors><pubmed_authors>Pardoll DM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Lung tumor-infiltrating T&amp;lt;sub&amp;gt;reg&amp;lt;/sub&amp;gt; have divergent transcriptional profiles and function linked to checkpoint blockade response.</name><description>Regulatory T cells (T&lt;sub>reg&lt;/sub>) are conventionally viewed as suppressors of endogenous and therapy-induced antitumor immunity; however, their role in modulating responses to immune checkpoint blockade (ICB) is unclear. In this study, we integrated single-cell RNA-seq/T cell receptor sequencing (TCRseq) of >73,000 tumor-infiltrating T&lt;sub>reg&lt;/sub> (TIL-T&lt;sub>reg&lt;/sub>) from anti-PD-1-treated and treatment-naive non-small cell lung cancers (NSCLC) with single-cell analysis of tumor-associated antigen (TAA)-specific T&lt;sub>reg&lt;/sub> derived from a murine tumor model. We identified 10 subsets of human TIL-T&lt;sub>reg&lt;/sub>, most of which have high concordance with murine TIL-T&lt;sub>reg&lt;/sub> subsets. Only one subset selectively expresses high levels of &lt;i>TNFRSF4&lt;/i> (OX40) and &lt;i>TNFRSF18&lt;/i> (GITR), whose engangement by cognate ligand mediated proliferative programs and NF-κB activation, as well as multiple genes involved in T&lt;sub>reg&lt;/sub> suppression, including &lt;i>LAG3&lt;/i>. Functionally, the OX40&lt;sup>hi&lt;/sup>GITR&lt;sup>hi&lt;/sup> subset is the most highly suppressive ex vivo, and its higher representation among total TIL-T&lt;sub>reg&lt;/sub> correlated with resistance to PD-1 blockade. Unexpectedly, in the murine tumor model, we found that virtually all TIL-T&lt;sub>reg&lt;/sub>-expressing T cell receptors that are specific for TAA fully develop a distinct T&lt;sub>H&lt;/sub>1-like signature over a 2-week period after entry into the tumor, down-regulating &lt;i>FoxP3&lt;/i> and up-regulating expression of &lt;i>TBX21 (&lt;/i>Tbet)&lt;i>, IFNG&lt;/i>, and certain proinflammatory granzymes. Transfer learning of a gene score from the murine TAA-specific T&lt;sub>H&lt;/sub>1-like T&lt;sub>reg&lt;/sub> subset to the human single-cell dataset revealed a highly analogous subcluster that was enriched in anti-PD-1-responding tumors. These findings demonstrate that TIL-T&lt;sub>reg&lt;/sub> partition into multiple distinct transcriptionally defined subsets with potentially opposing effects on ICB-induced antitumor immunity and suggest that TAA-specific TIL-T&lt;sub>reg&lt;/sub> may positively contribute to antitumor responses.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Sep</publication><modification>2026-05-28T22:28:57.347Z</modification><creation>2025-04-06T08:04:15.126Z</creation></dates><accession>S-EPMC10629528</accession><cross_references><pubmed>37713507</pubmed><doi>10.1126/sciimmunol.adg1487</doi></cross_references></HashMap>